These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31843228)

  • 1. The surgeon's role in optimizing medical therapy and maintaining compliance with secondary prevention guidelines in patients undergoing coronary artery bypass grafting.
    Lazar HL
    J Thorac Cardiovasc Surg; 2020 Sep; 160(3):691-698. PubMed ID: 31843228
    [No Abstract]   [Full Text] [Related]  

  • 2. Status of secondary prevention in patients undergoing coronary revascularization.
    Allen JK; Blumenthal RS; Margolis S; Young DR
    Am J Cardiol; 2001 May; 87(10):1203-6: A7. PubMed ID: 11356400
    [No Abstract]   [Full Text] [Related]  

  • 3. Interventions to improve guideline compliance following coronary artery bypass grafting.
    Yam FK; Akers WS; Ferraris VA; Smith K; Ramaiah C; Camp P; Flynn JD
    Surgery; 2006 Oct; 140(4):541-7; discussion 547-52. PubMed ID: 17011901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-lowering therapy after coronary artery bypass grafting: time for more aggressive intervention.
    Lucas BD
    Am J Health Syst Pharm; 2002 Nov; 59(21):2101-3. PubMed ID: 12434726
    [No Abstract]   [Full Text] [Related]  

  • 5. Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.
    Kumbhani DJ; Fonarow GC; Cannon CP; Hernandez AF; Peterson ED; Peacock WF; Laskey WK; Deedwania P; Grau-Sepulveda M; Schwamm LH; Bhatt DL;
    Am J Med; 2015 Apr; 128(4):426.e1-9. PubMed ID: 25433302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
    Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
    Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of statin therapy in the coronary bypass patient.
    Lazar HL
    Ann Thorac Surg; 2004 Aug; 78(2):730-40. PubMed ID: 15276569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiological medical treatment after coronary bypass surgery].
    Donas-Boto Bordalo A; Nobre A; Serra Coelho A; Cravino J
    Rev Port Cir Cardiotorac Vasc; 2009; 16(1):19-25. PubMed ID: 19503849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Stein PD; Schünemann HJ; Dalen JE; Gutterman D
    Chest; 2004 Sep; 126(3 Suppl):600S-608S. PubMed ID: 15383486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Placement of Aortic Transcatheter Valve (PARTNER) trial: the surgeon's perspective: celebration and concern.
    Guyton RA
    Circulation; 2012 Jun; 125(25):3237-9. PubMed ID: 22733339
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term results of coronary artery bypass grafting.
    Kanagasabay RR; Parker DJ
    Curr Opin Cardiol; 1996 Nov; 11(6):568-73. PubMed ID: 8968670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prompt impact of first prospective statin mega-trials on postoperative lipid management of CABG patients: a 20-year follow-up in a single hospital.
    Palomäki A; Hällberg V; Ala-Korpela M; Kovanen PT; Malminiemi K
    Lipids Health Dis; 2016 Jul; 15(1):124. PubMed ID: 27460359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting.
    Kim DH; Daskalakis C; Silvestry SC; Sheth MP; Lee AN; Adams S; Hohmann S; Medvedev S; Whellan DJ
    J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1377-84. PubMed ID: 19931667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving trends of reoperative coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons Adult Cardiac Surgery Database.
    Ghanta RK; Kaneko T; Gammie JS; Sheng S; Aranki SF
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):364-72. PubMed ID: 23321128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting: A Surgical Perspective.
    Gaudino M; Taggart DP
    JAMA Cardiol; 2019 Jun; 4(6):505-506. PubMed ID: 31017624
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.
    Kulik A; Chan V; Ruel M
    Expert Opin Drug Saf; 2009 Mar; 8(2):169-82. PubMed ID: 19309245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting.
    Bybee KA; Powell BD; Valeti U; Rosales AG; Kopecky SL; Mullany C; Wright RS
    Circulation; 2005 Aug; 112(9 Suppl):I286-92. PubMed ID: 16159833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [After bypass surgery nearly all lipids are in the normal range. However, Lp(a) is too high, what can be done?].
    Parhofer KG
    MMW Fortschr Med; 2011 May; 153(21):22. PubMed ID: 21736061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.